Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06498037
PHASE4

Optimizing Subcutaneous FEntanyl titRation: RApid Achievement of Adequate Exposure When Treating Cancer-Related paIn.

Sponsor: Erasmus Medical Center

View on ClinicalTrials.gov

Summary

The primary objective is to evaluate the effect of loading boluses when dose incresaing treatment with SC fentanyl in patients with cancer. The primary endpoint of this study is to prove the non-inferiority of fentanyl plasma concentrations 12 hours after dose augmentation compared to 48 hours after dose augmentation within each patient. Patients will be treated with additional loading boluses and plasma-PK samples will be obtained.

Key Details

Gender

All

Age Range

18 Years - 120 Years

Study Type

INTERVENTIONAL

Enrollment

45

Start Date

2024-02-23

Completion Date

2025-12-02

Last Updated

2024-07-12

Healthy Volunteers

No

Conditions

Interventions

DRUG

Fentanyl

Administration of subcutaneously administered fentanyl loading boluses

Locations (1)

Erasmus Medical Center

Rotterdam, South Holland, Netherlands